SFS
AUTL

Sowell Financial Services’s Autolus Therapeutics AUTL Stock Holding History

Sowell Financial Services’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,500
Closed -$8K – 687
2021
Q1 		$8K Buy
+1,500
New +$11.1K ﹤0.01% 2391

Other funds holding AUTL

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Sowell Financial Services's AUTL Position: Q2 2021 in Review

Sowell Financial Services sold out of Autolus Therapeutics (AUTL) in Q2 2021, closing a stake of 1,500 shares — an estimated $8K sold.

Sowell Financial Services first reported a position in AUTL in Q1 2021 and held it in 1 quarter. The position peaked at $8K in Q1 2021. 69 funds tracked by Wall St. Rank hold AUTL as of Q2 2021.

  • Sowell Financial Services reported no remaining Autolus Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,500 Autolus Therapeutics shares in Q2 2021, an estimated $8K.
  • Sowell Financial Services first reported a position in Autolus Therapeutics in Q1 2021 and held it in 1 quarter.
  • Sowell Financial Services's Autolus Therapeutics position peaked at $8K in Q1 2021.
  • 69 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.